# ROFLUMILAST
> **ANDA208299** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2022-05-10
## Drug
- **FDA Application Number:** ANDA208299
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ROFLUMILAST
- **Generic name:** ROFLUMILAST
- **Active ingredients:** ROFLUMILAST
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PRINSTON INC
- **Manufacturer:** Solco Healthcare US, LLC.
- **First approval:** 2022-05-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208299)
---
*AI Analytics · CC0 1.0*